These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17507484)

  • 21. Hepatitis C virus nonstructural protein 4B induces lipogenesis via the Hippo pathway.
    Zou C; Tan H; Zeng J; Liu M; Zhang G; Zheng Y; Zhang Z
    Arch Virol; 2023 Mar; 168(4):113. PubMed ID: 36920600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism.
    Shimano H
    Vitam Horm; 2002; 65():167-94. PubMed ID: 12481547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core.
    Jackel-Cram C; Babiuk LA; Liu Q
    J Hepatol; 2007 Jun; 46(6):999-1008. PubMed ID: 17188392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus proteins induce lipogenesis and defective triglyceride secretion in transgenic mice.
    Lerat H; Kammoun HL; Hainault I; Mérour E; Higgs MR; Callens C; Lemon SM; Foufelle F; Pawlotsky JM
    J Biol Chem; 2009 Nov; 284(48):33466-74. PubMed ID: 19808675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver.
    Ryan MC; Desmond PV; Slavin JL; Congiu M
    J Viral Hepat; 2011 Jan; 18(1):53-60. PubMed ID: 20196803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis.
    Piodi A; Chouteau P; Lerat H; Hézode C; Pawlotsky JM
    Hepatology; 2008 Jul; 48(1):16-27. PubMed ID: 18570290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorption.
    Khaleel EF; Abdel-Aleem GA; Mostafa DG
    Can J Physiol Pharmacol; 2018 Feb; 96(2):145-157. PubMed ID: 28777914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma.
    Kim KH; Shin HJ; Kim K; Choi HM; Rhee SH; Moon HB; Kim HH; Yang US; Yu DY; Cheong J
    Gastroenterology; 2007 May; 132(5):1955-67. PubMed ID: 17484888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV and host lipids: an intimate connection.
    Schaefer EA; Chung RT
    Semin Liver Dis; 2013 Nov; 33(4):358-68. PubMed ID: 24222093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.
    Khan M; Jahan S; Khaliq S; Ijaz B; Ahmad W; Samreen B; Hassan S
    Arch Virol; 2010 Nov; 155(11):1735-53. PubMed ID: 20842391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of an in vitro model to study hepatitis C virus effects on hepatocellular lipotoxicity and lipid metabolism.
    Koletzko L; Mahli A; Hellerbrand C
    Pathol Res Pract; 2018 Oct; 214(10):1700-1706. PubMed ID: 30201523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TAK1 regulates hepatic lipid homeostasis through SREBP.
    Morioka S; Sai K; Omori E; Ikeda Y; Matsumoto K; Ninomiya-Tsuji J
    Oncogene; 2016 Jul; 35(29):3829-38. PubMed ID: 26973245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chrysin reduces the activity and protein level of mature forms of sterol regulatory element-binding proteins.
    Iwase M; Watanabe K; Shimizu M; Suzuki T; Yamamoto Y; Inoue J; Sato R
    Biosci Biotechnol Biochem; 2019 Sep; 83(9):1740-1746. PubMed ID: 31021712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner.
    Gao TT; Qin ZL; Ren H; Zhao P; Qi ZT
    Virol J; 2015 Feb; 12():12. PubMed ID: 25645159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SREBPs: metabolic integrators in physiology and metabolism.
    Jeon TI; Osborne TF
    Trends Endocrinol Metab; 2012 Feb; 23(2):65-72. PubMed ID: 22154484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of the SREBP transcription factors by mTORC1.
    Lewis CA; Griffiths B; Santos CR; Pende M; Schulze A
    Biochem Soc Trans; 2011 Apr; 39(2):495-9. PubMed ID: 21428927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steatosis and insulin resistance in hepatitis C: a way out for the virus?
    Del Campo JA; Romero-Gómez M
    World J Gastroenterol; 2009 Oct; 15(40):5014-9. PubMed ID: 19859993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus genotypes 1-3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes.
    Hsu CS; Liu WL; Li Q; Lowey B; Hertz L; Chao YC; Liang TJ; Chen DS; Kao JH
    J Formos Med Assoc; 2020 Sep; 119(9):1382-1395. PubMed ID: 32284164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?
    Nakamuta M; Yada R; Fujino T; Yada M; Higuchi N; Tanaka M; Miyazaki M; Kohjima M; Kato M; Yoshimoto T; Harada N; Taketomi A; Maehara Y; Koga M; Nishinakagawa T; Nakashima M; Kotoh K; Enjoji M
    Int J Mol Med; 2009 Dec; 24(6):825-8. PubMed ID: 19885625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct-acting antiviral agents against hepatitis C virus and lipid metabolism.
    Kanda T; Moriyama M
    World J Gastroenterol; 2017 Aug; 23(31):5645-5649. PubMed ID: 28883690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.